Saint-Gobain adds high purity option to Sani-Tech line

Published: 24-Jan-2012
Manufacturing

Ultra-HP combines reinforced outer jacket with fully bonded FEP liner

Saint-Gobain has added the Sani-Tech Ultra-HP high purity hose to its Sani-Tech line of fluid transfer products.

Ultra-HP combines a tough outer jacket and hose comprising multiple layers of Sani-Tech Ultra platinum-cured silicone and 316L stainless steel helical wire reinforcement with a PharmaFluor FEP liner. The liner's smooth inner bore surface provides both optimal flow and ease of cleaning and sanitisation.

The PharmaFluor FEP liner is said to minimise bonding of biological materials and maintains fluid purity due to low TOCs, extractables and leachables. The liner is fully bonded to the silicone hose using a patented bonding technology, which helps ensure a high purity fluid path.

The company says the hose's overall light weight, low force to bend and exceptional flexibility make it suitable for a variety of applications, including bioprocessing, load cells, product transfer and steam-in-place/clean-in-place (SIP/CIP).

Sani-Tech Ultra-HP hose is made from USP Class VI compliant materials and certified to meet USP <88>, USP <87>, EP 3.1.9, ISO 10993, FDA 21 CFR 177.2600 and FDA 21 CFR 177.1550 requirements.

See more

You may also like

Design & Build

Saint-Gobain completes Florida stage of global manufacturing expansion

Read more
French manufacturer is spending $77.5m on a global component manufacturing expansion programme spanning seven sites

Trending Articles

  1. Compact, economical and sustainable cooling solutions for laboratories Huber Unichillers offer space-saving and environmentally friendly temperature control for research and industrial applications
  2. Aragen to manufacture Renaissance Pharma’s FDA Fast Track mAb as part of ongoing strategic collaboration CRDMO successfully scaled and transferred Renaissance Pharma’s lead candidate, Daretabart a humanised monoclonal antibody targeting GD2 for high-risk neuroblastoma, in just 9 months
  3. Bruker announces major strides in 4D proteomics performance, further advances In intact and top-down functional proteoform analysis, and innovations in hybrid qual/quant 4D metabolomics All to enable deeper insights into disease biology. Bruker Also Launches Two Novel Mass Spectrometry Systems for Unique Applications in Energy Industry Research, and in Semiconductor Manufacturing
  4. CEPI fast-tracks three Bundibugyo ebolavirus vaccine candidates amid DRC outbreak With no licensed vaccines available and more than 900 suspected cases already recorded, CEPI is urgently advancing mRNA, rVSV and viral vector candidates from Moderna, IAVI and Oxford/SII toward clinical trials
  5. FDA Form 483 flags falsified records and live bird infestation at Dabur India OTC plant A FDA inspection report issued in January 2026 has revealed widespread CGMP failures at Dabur India's Dadra and Nagar Haveli facility, including manipulated microbiology data, fraudulent equipment logs and unsanitary storage conditions

Upcoming event

BIO International Convention

22–25 June 2026 | Convention | Boston, US See all

You may also like

Design & Build

Saint-Gobain completes Florida stage of global manufacturing expansion

French manufacturer is spending $77.5m on a global component manufacturing expansion programme spanning seven sites
Manufacturing

Saint-Gobain Performance Plastics acquires Applied Bioprocess Containers

Taking advantage of its expertise in the design and manufacture of bioprocess containers
Manufacturing

Saint-Gobain Sani-Tech Ultra tubing delivers improved performance

Saint-Gobain Performance Plastics in the US has added Sani-Tech Ultra platinum-cured silicone tubing to its portfolio
Manufacturing

Safety in pharmaceutical manufacturing: why a trusted partner makes all the difference

By taking a three-tiered approach to protecting patients and personnel and ensuring plant compliance, GEA adopts a consultative approach to helping its customers navigate the responsibilities of pharmaceutical manufacturing safety with confidence
Manufacturing

Aragen to manufacture Renaissance Pharma’s FDA Fast Track mAb as part of ongoing strategic collaboration

CRDMO successfully scaled and transferred Renaissance Pharma’s lead candidate, Daretabart a humanised monoclonal antibody targeting GD2 for high-risk neuroblastoma, in just 9 months
Manufacturing

Cutting-edge wiped film evaporator installation – non-tobacco nicotine products

Successful system installation for a UK research and development facility developing and commercialising non-tobacco nicotine products using industry-leading evaporation equipment
Manufacturing

Next expansion milestone achieved: SCHOTT Pharma opens production facility in Serbia to strengthen competitiveness in Europe

After a double-digit million euro investment and less than 1.5 years of construction, SCHOTT Pharma opens new manufacturing site in Jagodina, Serbia. Production capacity to meet European market demand for pharmaceutical ampoules. Facility brings around 180 new jobs to the region
Subscribe now